Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Despite Launches from Streaming Rivals, Netflix Stock Will Soon Rebound

By Chris Lau, InvestorPlace Contributor

The customer base may try out other services while keeping an inexpensive Netflix subscription. That could lead to strong revenue growth. That may send NFLX stock back up.

Apple Stock Still Is a Buy as the Trade War Escalates

By Chris Lau, InvestorPlace Contributor

Apple stock may face resumed selling pressure as markets worry over the escalating trade war. The stock's dip creates an entry point.

7 of the Best Financial Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor

Financial stocks have been beaten up on fears of a slowing economy and lower interest rates. But it's actually not all doom and gloom.

Why Aphria Is the Best Cannabis Stock to Buy

By Chris Lau, InvestorPlace Contributor

The rally in Aphria stock on August 2 faded. But investors are ignoring the long-term potential growth ahead.

Why Investors Should Buy the Dip After IBM Shares Fell

By Chris Lau, InvestorPlace Contributor

IBM is trading at a discount. Again. Markets ignore the strong growth Red Hat brings to its business, improving long-term prospects.

Load More